Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04714216 · ClinicalTrials.gov registry record · NA

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

A NA study of Diabetes Mellitus, sponsored by Emory University.

Completed
Registry status
NA
Development phase
22
Enrollment target
3
Study locations

NCT04714216 is a NA study of Diabetes Mellitus that has completed, run by Emory University. The registered enrollment target is 22 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04714216, a NA study of Diabetes Mellitus, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
3
Study locations

Study Summary

This single-arm stepwise feasibility study will test initial deployment of hybrid closed-loop (HCL) automated insulin delivery (AID) using the Omnipod 5/Horizon HCL system with remote monitoring and device operation capabilities to hospitalized patients admitted to the general medical/surgical floor with diabetes (type 1 or type 2) requiring insulin therapy.

Conditions Studied

Diabetes Mellitus

Interventions

  • DEVICE The Omnipod 5/Horizon HCL system

Study Locations (3)

California

  • Stanford University School of Medicine - Stanford

Georgia

  • Grady Health System (non-CRN) - Atlanta

Virginia

  • University of Virginia School of Medicine - Charlottesville

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2021-06-29
Est. Completion 2022-08-11
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04714216

The ClinicalTrials.gov registry entry for NCT04714216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which The Omnipod 5/Horizon HCL system is the first listed.

NCT04714216 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Georgia, Virginia.

Frequently Asked Questions

What is clinical trial NCT04714216 about?

NCT04714216 is a clinical study titled "Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility". This single-arm stepwise feasibility study will test initial deployment of hybrid closed-loop (HCL) automated insulin delivery (AID) using the Omnipod 5/Horizon HCL system with remote monitoring and device operation capabilities to hospitalized patients admitted to the general medical/surgical floor...

What is the current status of trial NCT04714216?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2021-06-29. Estimated completion is 2022-08-11.

What conditions does trial NCT04714216 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT04714216?

The interventions under investigation include: The Omnipod 5/Horizon HCL system (DEVICE).

Who is sponsoring clinical trial NCT04714216?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04714216 being conducted?

This trial has 3 study locations across California, Georgia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.